Roche may have scrapped work on a T-cell engager (TCE) for lupus, but the company’s head of pharma told Fierce Biotech that ...
Roche's AXELIOS 1 enters next generation DNA sequencing. Can it or rivals unseat Illumina's long-standing market dominance?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results